nach oben

Reactions Weekly

Erschienen in:

01.08.2023 | Case report

Mepolizumab/prednisolone

Psoriasis vulgaris and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Yokota N, et al. Psoriasis-like skin rash triggered by a local infection in a patient with eosinophilic granulomatosis with polyangiitis that was well controlled by mepolizumab treatment. Clinical Case Reports 11: No. 6, Jun 2023. Available from: URL: http://dx.doi.org/10.1002/ccr3.7532

Titel: Mepolizumab/prednisolone
Psoriasis vulgaris and lack of efficacy: case report
Publikationsdatum: 01.08.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-44359-z

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Multiple drugs

Norepinephrine

Covid-19-vaccine

Hyoscine hydrobromide patches: risk of anticholinergic side effects

Fentanyl/naldemedine

Tozinameran